Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1981 |
| gptkbp:ATCCode |
gptkb:C08CA05
|
| gptkbp:availableOn |
capsule
extended-release tablet |
| gptkbp:brand |
gptkb:nifedipine
|
| gptkbp:contraindication |
severe aortic stenosis
|
| gptkbp:drugClass |
beta blocker
|
| gptkbp:eliminationHalfLife |
2-5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Procardia
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
edema
dizziness headache flushing |
| gptkbp:usedFor |
hypertension
angina |
| gptkbp:bfsParent |
gptkb:nifedipine
|
| gptkbp:bfsLayer |
6
|